FedInvent™ Patent Applications

New Taxpayer Funded Applications for Thursday, April 27, 2023 

This page was updated on Thursday, April 27, 2023 at 11:00 AM GMT

FedInvent analyzed 152 taxpayer funded patent applications this week.

On Thursday, April 27, 2023, the United States Patent and Trademark Office (USPTO) published  152 patent applications; including 143 applications containing government interest statements and 22 applications where federal government agencies were an assignee or applicant on the patent application. Together, 152 patent applications published this week are the result of U.S. Government funded research & development.

Learn More About Taxpayer Funded Patents Here

The List of This Week's Patent Applications

Just a list — patent application publication number with a link and the title, for those patentistas who like to browse.

About The Icons On the List Below

  • The icon takes you to the full text version of the patent application at USPTO;
  • The icon takes you to the PDF version of the patent application at USPTO; and
  • The icon takes you to the details about the patent on the FedInvent Details page.
  • When you use the icon the patent you are interested appears at the top of the list on the details page.
Patent Application Title
001 20230125131
 
ULTRAFAST LIGHT FIELD TOMOGRAPHY 
002 20230125162
 
SIMULTANEOUS BEAMFORMING AND NULLFORMING FOR SECURE WIRELESS COMMUNICATIONS 
003 20230125242
 
ELECTROCHEMICAL Ca(OH)2 AND/OR Mg(OH)2 PRODUCTION FROM INDUSTRIAL WASTES AND Ca/Mg-CONTAINING ROCKS 
004 20230125317
 
Avalanche Photodiodes with Adaptive Quenching of Photocurrent 
005 20230125415
 
BIOMARKERS FOR PREDICTING RESPONSE TO IL-6 ANTAGONIST IN COVID-19 PNEUMONIA 
006 20230125467
 
IMAGE-BASED HEALTH INDEX SCORING SYSTEM FOR GENITOURINARY TRACT 
007 20230125614
 
IN VIVO mRNA DISPLAY: LARGE-SCALE PROTEOMICS BY NEXT GENERATION SEQUENCING 
008 20230125667
 
NOVEL TDZD ANALOGS AS AGENTS THAT DELAY, PREVENT, OR REVERSE AGE-ASSOCIATED DISEASES AND AS ANTI-CANCER AND ANTILEUKEMIC AGENTS 
009 20230125788
 
TDP-43 MODULATING AGENTS AND USES THEREOF 
010 20230125793
 
METHOD OF MAKING HEXAGONAL BORON NITRIDE COATINGS AND COMPOSITIONS AND METHODS OF USING SAME 
011 20230125840
 
Variable Displacement Pumps 
012 20230125881
 
NOVEL POLYPEPTIDES AND USES THEREOF 
013 20230125917
 
METHOD OF TREATING MICROBIAL INFECTIONS 
014 20230125924
 
MULTI-FUNCTIONAL EQUIPMENT FOR DIRECT DECARBONIZATION WITH IMPROVED INDOOR AIR QUALITY 
015 20230125935
 
GENETIC ELEMENTS DRIVING CIRCULAR RNA TRANSLATION AND METHODS OF USE 
016 20230126087
 
SYSTEMS AND METHODS FOR CONTROLLING AN INDUSTRIAL ASSET IN THE PRESENCE OF A CYBER ATTACK 
017 20230126276
 
FENTANYL HAPTENS, FENTANYL HAPTEN CONJUGATES, AND METHODS FOR MAKING AND USING 
018 20230126288
 
COLLAPSIBLE TUBULAR MAST (CTM) WITH SURFACE MATERIAL BETWEEN TRUSSES 
019 20230126296
 
SYSTEMS AND METHODS FOR GUIDED INTERVENTION 
020 20230126364
 
SYSTEMS AND SIGNAL PROCESSING METHODS FOR REAL-TIME TRAFFIC CONGESTION DETECTION 
021 20230126388
 
INLINE PNEUMATIC VALVE WITH INTERNAL BUSHING 
022 20230126396
 
Compositions and Administration of Chimeric Glycoprotein Lyssavirus Vaccines for Coverage Against Rabies 
023 20230126413
 
D-GLUCOSE AND ITS ANALOGS AS TRACERS TO ASSESS THE GLUCOSE TRANSPORTER FUNCTION ON BLOOD-CEREBROSPINAL FLUID BARRIER AND THE FUNCTIONING OF THE BRAIN LYMPHATIC SYSTEM 
024 20230126417
 
METHOD OF MAKING THIN FILMS OF SODIUM FLUORIDES AND THEIR DERIVATIVES BY ALD 
025 20230126460
 
SYSTEM AND METHOD FOR PREDICTING MACHINE FAILURE 
026 20230126514
 
GENETICALLY ENGINEERED MICROORGANISMS THAT OVEREXPRESS MICROCIN-MGE AND METHODS OF PURIFICATION AND USE 
027 20230126533
 
Method of treating an inflammatory disorder 
028 20230126566
 
TRACKING CONTINUOUSLY SCANNING LASER DOPPLER VIBROMETER SYSTEMS AND METHODS 
029 20230126674
 
Prosthetic Foot/Ankle System with Automatic Alignment 
030 20230126784
 
A METHOD TO GENERATE CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS (CAR-T CELLS) FROM PATHOGEN-SPECIFIC CYTOTOXIC LYMPHOCYTES TO ENABLE THE SUBSEQUENT IN VIVO MODULATION OF THEIR FUNCTIONAL ACTIVITY 
031 20230126796
 
FUNCTIONAL AND THERAPEUTIC EFFECTS OF PAR4 CLEAVAGE BY CATHEPSIN G 
032 20230126905
 
LEAD LOCKING SYSTEM AND METHOD FOR IMPLANTABLE STIMULATORS 
033 20230126916
 
Relatively constant sensor application pressure for electrical impedance myography 
034 20230126966
 
SYNTHETIC QUORUM-REGULATED LYSIS 
035 20230126976
 
Inflatable Pillow, Compartmental Pillow, and Pillow Dispenser 
036 20230127008
 
STAT3-TARGETED BASE EDITOR THERAPEUTICS FOR THE TREATMENT OF MELANOMA AND OTHER CANCERS 
037 20230127014
 
Method for Manufacturing Transparent Ceramic Materials 
038 20230127031
 
ROBUST FRAMEWORK FOR INTELLIGENT NEURAL INTERFACE SYSTEMS 
039 20230127106
 
PINCHED TUBES FOR RECONFIGURABLE ROBOTS 
040 20230127123
 
ANTIBODIES AGAINST PD-L1 AND METHODS OF USE THEREOF 
041 20230127207
 
METHODS AND SYSTEMS FOR IMPROVED TEST FUEL REACTOR 
042 20230127263
 
MODIFIED T CELLS AND METHODS OF PREPARING THE SAME 
043 20230127277
 
MICROBIOME-BASED THERAPEUTICS 
044 20230127304
 
NEW INHIBITORS FOR THE KEAP1-NRF2 PROTEIN-PROTEIN INTERACTION 
045 20230127343
 
AUTOMATIC THREAT RECOGNITION FOR HD AIT 
046 20230127401
 
MACHINE LEARNING SYSTEMS USING ELECTRONIC HEALTH RECORD DATA AND PATIENT-REPORTED OUTCOMES 
047 20230127462
 
Modified Tetracycline for Treatment of Alcohol Use Disorder, Pain and Other Disorders Involving Potential Inflammatory Processes 
048 20230127487
 
ASSESSING AND TREATING ACUTE DECOMPENSATED HEART FAILURE 
049 20230127524
 
FILAMENTOUS NANOSTRUCTURES AND THEIR USE FOR TREATMENT OF PULMONARY DISEASE 
050 20230127548
 
METHODS FOR IDENTIFYING A CELL UPTAKE MECHANISM 
051 20230127630
 
IGF2BP2 INHIBITORS AND USES THEREOF 
052 20230127633
 
INHIBITORS OF OXIDIZED LOW-DENSITY LIPOPROTEIN RECEPTOR 1 AND METHODS OF USE THEREOF 
053 20230127636
 
COMPOUNDS FOR TREATING ILK-MEDIATED DISEASES 
054 20230127686
 
FATTY AMMONIUM SALT STARCH COMPLEXES AS PLANT WOUND PROTECTANTS AND ANTIMICROBIALS FOR WOUND DRESSINGS 
055 20230127698
 
AUTOMATED STEREOLOGY FOR DETERMINING TISSUE CHARACTERISTICS 
056 20230127768
 
TRANSISTOR WITH WRAP-AROUND EXTRINSIC BASE 
057 20230127791
 
LASER MACHINING AND RELATED CONTROL FOR ADDITIVE MANUFACTURING 
058 20230127819
 
TREATING PER- AND POLY-FLUOROALKYL SUBSTANCES IN LANDFILL LEACHATE 
059 20230127823
 
Non-Invasive Gene Mutation Detection in Lung Cancer Patients 
060 20230127827
 
Broadband Diffractive Optical Element 
061 20230127834
 
Trunk Exoskeleton 
062 20230127861
 
METHODS AND COMPOSITIONS FOR THE TREATMENT OF PULMONARY FIBROSIS USING VOLASERTIB 
063 20230127880
 
PLANT FEATURE DETECTION USING CAPTURED IMAGES 
064 20230127944
 
BROAD-SPECTRUM CARBAPENEMS 
065 20230127948
 
FIELD DEPLOYABLE CRISPR-CAS DIAGNOSTICS AND METHODS OF USE THEREOF 
066 20230128029
 
NEUROKININ ANTAGONISTS AND USES THEREOF 
067 20230128071
 
MULTI-PIECE BUSHING 
068 20230128072
 
UV-LED Induction of Measurable Biological Endpoints 
069 20230128120
 
OMEGA MURICHOLIC ACID AS A PREGNANE X RECEPTOR LIGAND FOR TREATING HEPATO-INTESTINAL DISEASES 
070 20230128143
 
METHOD FOR TREATING CANCER 
071 20230128159
 
SYSTEM FOR LUBRICATING COMPONENTS OF A GAS TURBINE ENGINE INCLUDING A LUBRICANT BYPASS CONDUIT 
072 20230128213
 
Phytol-based surfactants and methods therefor 
073 20230128322
 
SYK KINASE INHIBITORS AS TREATMENT FOR MALARIA 
074 20230128340
 
SELECTIVE IMMUNODEPLETION OF ENDOGENOUS STEM CELL NICHE FOR ENGRAFTMENT 
075 20230128344
 
SITE-SPECIFIC ANTIBODY-DRUG CONJUGATES BY ADP-RIBOSYL CYCLASES 
076 20230128586
 
SUPERCONDUCTING DC SWITCH SYSTEM 
077 20230128630
 
UNFOLDER-BASED SINGLE-STAGE AC-AC CONVERSION SYSTEM 
078 20230128716
 
DEVICES, COMPOSITIONS AND METHODS FOR IMAGING WITH RAMAN SCATTERING 
079 20230128722
 
BEAD INCUBATION AND WASHING ON A DROPLET ACTUATOR 
080 20230128742
 
Systems and Methods for Communicating by Modulating Data on Zeros 
081 20230128829
 
RADIO FREQUENCY TUNING USING A MULTICHIP MODULE ELECTRICAL INTERCONNECT STRUCTURE 
082 20230128967
 
SYSTEM, METHOD, AND COMPUTER PROGRAM PRODUCT FOR ADDITIVE MANUFACTURING OF BIOMIMETIC COMPONENTS FROM A BUILDING MATERIAL ON A MOVING BUILD PLATFORM 
083 20230128970
 
UNFOLDER-BASED SINGLE-STAGE AC-AC CONVERSION SYSTEM 
084 20230129191
 
Atomic Layer-Based Surface Treatments for Infrared Detectors 
085 20230129271
 
COMPOSITIONS AND METHODS FOR TREATING CANCER 
086 20230129326
 
METHODS TO PREVENT SARS-COV-2 INFECTION AND TREAT COVID-19 
087 20230129378
 
SYSTEMS AND METHODS FOR DETECTION OF ANALYTES 
088 20230129381
 
COMPOSITIONS AND METHODS FOR TREATMENT OF ANTICANCER-DRUG RESISTANT CANCERS 
089 20230129434
 
ELECTROCHEMICAL THREE-DIMENSIONAL PRINTING AND SOLDERING 
090 20230129463
 
METHODS AND SYSTEMS FOR DATA AUTHENTICATION SERVICES 
091 20230129475
 
3D MICROELECTRODE ARRAYS (3D MEAS) WITH MULTIPLE SENSING CAPABILITIES FOR THE INVESTIGATION OF ELECTROGENIC CELLS 
092 20230129487
 
SMALL MOLECULE BCL-2 FUNCTIONAL CONVERTERS AS CANCER THERAPEUTICS 
093 20230129517
 
SYSTEM AND METHOD FOR TISSUE VIABILITY SCREENING 
094 20230129562
 
SYSTEMS AND METHODS FOR OPTIMAL STATE TRANSFER AND ENTANGLEMENT GENERATION IN POWER-LAW INTERACTING SYSTEMS 
095 20230129574
 
EQUIPMENT AND METHODS FOR REMOTE NEUROPSYCHOLOGICAL ASSESSMENT 
096 20230129745
 
COMPOUNDS, COMPOSITIONS, AND METHODS TO TREAT METABOLIC DISEASE 
097 20230129777
 
Laser Deposition with a Reactive Gas 
098 20230129789
 
METHODS FOR REGULATING FREE FATTY ACID FLUX USING FAT SPECIFIC PROTEIN 27 (FSP27) COMPOSITIONS 
099 20230129915
 
SYSTEMS AND METHODS FOR ABRASIVE OXIDE REMOVAL IN ADDITIVE MANUFACTURING PROCESSES 
100 20230129962
 
TONGUE JOINT INCLUDING MATING CHANNEL FOR COOLING 
101 20230130102
 
Na/K-ATPase LIGANDS AND USE THEREOF FOR TREATMENT OF CANCER 
102 20230130218
 
IMMUNOTHERAPEUTIC MODULATION OF AMYLOIDOGENIC DISEASE USING NON-FIBRILLOGENIC, NON-AMYLOIDOGENIC POLYMERIZED PROTEINS AND PEPTIDES 
103 20230130243
 
Method of Treating Urothelial Carcinoma and Other Genitourinary Malignancies Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N\'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 
104 20230130325
 
SERUM METABOLITES AS BIOMARKERS FOR CARNITINE TREATMENT OF SEPSIS 
105 20230130372
 
NOVEL DDR1 ANTIBODIES AND USES THEREOF 
106 20230130579
 
REGULATION OF POST-ISCHEMIC INFLAMMATORY RESPONSE: A NOVEL FUNCTION OF TYROSINE PHOSPHATASE STEP 
107 20230130602
 
INHIBITORS OF C. DIFFICILE SPORE GERMINATION 
108 20230130671
 
Metal-Organic Chalcogenolates 
109 20230130680
 
ROBOT SKIN APPARATUS, METHOD OF FABRICATING A ROBOT SKIN APPARATUS, AND A SYSTEM INCLUDING A ROBOT SKIN APPARATUS 
110 20230130686
 
DEVICES AND SYSTEMS FOR DELIVERY OF MATERIALS TO CELLS 
111 20230130711
 
SYSTEM AND METHOD FOR THERMIONIC ENERGY CONVERSION 
112 20230130721
 
INTENSIFIED CARBON CAPTURE USING BUILDING INFRASTRUCTURE 
113 20230130766
 
MONO AND COMBINATION THERAPIES WITH ULK1/2 INHIBITORS 
114 20230130791
 
A Combined Inhibition of EGFR and NRF2 in The Treatment of Malignant Glioma 
115 20230130831
 
METHODS FOR DETECTING AND TREATING JOINT DISEASE 
116 20230130863
 
METHOD FOR SIGNAL REPRESENTATION AND RECONSTRUCTION 
117 20230130997
 
VARIABLE DISPLACEMENT PUMPS 
118 20230131058
 
MAGNETIZATION-FREE FARADAY ROTATORS 
119 20230131116
 
Method of Evanescently Coupling Whispering Gallery Mode Optical Resonators Using Liquids 
120 20230131140
 
HUMAN ORIGIN PROBIOTIC LACTOBACILIUS RHAMNOSUS HL-200 TO REDUCE LEAKY GUT BY METABOLIZING ETHANOLAMINE 
121 20230131219
 
USE OF AGONISTS TO AUGMENT CAR T FUNCTION IN SOLID TUMORS 
122 20230131243
 
METHODS OF ATTENUATING AN IMMUNE RESPONSE BY INHIBITION OF BFL1 
123 20230131300
 
Catalyst Compositions Including Metal Chalcogenides, Processes for Forming the Catalyst Compositions, and Uses Thereof 
124 20230131376
 
ADJUVANT-ANTIBIOTIC COMBINATION AGAINST GRAM-NEGATIVE BACTERIA 
125 20230131389
 
QUANTUM INSTRUCTION SET ARCHITECTURE (QUASAR) 
126 20230131501
 
THERAPEUTIC USES OF INHIBITORS OF THE RNA-BINDING PROTEIN HuR 
127 20230131584
 
MULTI-TONE CONTINUOUS WAVE DETECTION AND RANGING 
128 20230131668
 
HEAT SHOCK PROTEIN MODULATORS AND ANTI-HUNTINGTON DISEASE THERAPEUTIC AGENTS 
129 20230131728
 
Sensor Assemblies and Methods for Emulating Interaction of Entities Within Water Systems 
130 20230131816
 
WEARABLE MICROPHONE JAMMER 
131 20230131867
 
TRITERPENE SAPONINS, METHODS OF SYNTHESIS AND USES THEREOF 
132 20230131883
 
METHOD FOR REMOVING ETHYLENE FROM AGRICULTURAL PRODUCTS 
133 20230131957
 
Unmanned Aerial Vehicle Self-Centering and Capture System and Related Methods 
134 20230131958
 
Cosmetic and Dermatological Compositions 
135 20230131972
 
RNA-Guided Transcriptional Regulation 
136 20230131980
 
NERVE STIMULATION FOR TREATMENT OF DISEASES AND DISORDERS 
137 20230132011
 
AREA SELECTIVE NANOSCALE-THIN LAYER DEPOSITION VIA PRECISE FUNCTIONAL GROUP LITHOGRAPHY 
138 20230132012
 
VERTICAL-VIA ROTARY VALVES, MICROBIOREACTORS AND APPLICATIONS OF SAME 
139 20230132026
 
X-Ray Scintillators, Metal Halide Hybrids, Devices, and Methods 
140 20230132031
 
NEUTRON ABSORBING EMBEDDED HYDRIDE SHIELD 
141 20230132034
 
Mesoporous MXene Powders Synthesized By Acid Or Base Induced Crumpling And Their Use As NA-Ion Battery Anodes 
142 20230132035
 
Toll-Like Receptor 8 (TLR8)-Specific Antagonists and Methods of Making and Uses Thereof 
143 20230132047
 
SWITCHED GRADIENT FIELD MEASUREMENT TECHNIQUES FOR SURFACE NMR 
144 20230132157
 
ANNULAR NUCLEAR FUEL ROD 
145 20230132184
 
METHODS AND SYSTEMS FOR PHYSICAL EXPANSION AND IMAGING OF BIOLOGICAL SAMPLES 
146 20230132224
 
Quantum-Confined Stark Effect Electro-Optic Modulator In Perovskite Quantum Wells Integrated On Silicon 
147 20230132279
 
SHORT CHAIN CERAMIDE-BASED LIPIDS AND USES THEREOF 
148 20230132281
 
RNA SEQUENCING TO DIAGNOSE SEPSIS 
149 20230132332
 
Green Methods of Carbohydrate Acetylation 
150 20230132355
 
DELIVERY OF CARD PROTEIN AS THERAPY FOR OCCULAR INFLAMMATION 
151 20230132381
 
SYNTHESIS OF FUNCTIONALIZABLE OR FUNCTIONALIZED POLY(3,4-ETHYLENEDIOXYTHIPHENE)-BASED POLYMERS AND MONOMERS THEREFOR 
152 20230132397
 
USE OF TOLL-LIKE RECEPTOR 2 (TLR-2) AGONIST FOR MODULATING HUMAN IMMUNE RESPONSE 

Up to Start Of Table

Patent Applications Count By Department

The count of taxpayer-funded patents granted by the United States Patent and Trademark Office (USPTO) this week that contain a Government Interest Statement in the body of the patent documents or where the government is an assignee. Agency numbers are aggregated by the agency named in the Government Interests Statement and the contract number cited in the patent.

Department This Week This Year
Department of Health and Human Services (HHS) 71 1149
Department of Defense (DOD) 33 596
National Science Foundation (NSF) 23 360
Department of Energy (DOE) 17 390
Department of Veterans Affairs (DVA) 9 41
National Aeronautics and Space Administration (NASA) 3 50
Small Business Administration (SBA) 3 37
Department of Agriculture (USDA) 2 38
Department of Commerce (DOC) 1 19
Department of Homeland Security (DHS) 1 16
Department of Transportation (USDOT) 1 9
Environmental Protection Agency (EPA) 1 6
United States Postal Service (USPS) 1 20
Government Rights Acknowledged 4 41

Patent Applications by Funding Agency

FedInvent Patents reflects patents with Government Interests Statements in the body of the patent as required by the Bayh-Dole Act indicating the holder of a federal contract, grant, or cooperative agreement has elected to retain the title of inventions conceived and reduced to practice during that contract; and patents where an agency of the US Federal government has elected to retain the title to the patent.

About The Icons On the List Below

  • The icon takes you to the full text version of the patent application at USPTO;
  • The icon takes you to the PDF version of the patent application at USPTO; and
  • The icon takes you to the details about the patent on the FedInvent Details page.
  • When you use the icon the patent you are interested appears at the top of the list on the details page.

Click the Panel to See The Patent Application for Each Agency

Take Me To The Details
Patent Title
001 20230125131
 
ULTRAFAST LIGHT FIELD TOMOGRAPHY 
002 20230125415
 
BIOMARKERS FOR PREDICTING RESPONSE TO IL-6 ANTAGONIST IN COVID-19 PNEUMONIA 
003 20230125467
 
IMAGE-BASED HEALTH INDEX SCORING SYSTEM FOR GENITOURINARY TRACT 
004 20230125614
 
IN VIVO mRNA DISPLAY: LARGE-SCALE PROTEOMICS BY NEXT GENERATION SEQUENCING 
005 20230125881
 
NOVEL POLYPEPTIDES AND USES THEREOF 
006 20230125917
 
METHOD OF TREATING MICROBIAL INFECTIONS 
007 20230125935
 
GENETIC ELEMENTS DRIVING CIRCULAR RNA TRANSLATION AND METHODS OF USE 
008 20230126276
 
FENTANYL HAPTENS, FENTANYL HAPTEN CONJUGATES, AND METHODS FOR MAKING AND USING 
009 20230126396
 
Compositions and Administration of Chimeric Glycoprotein Lyssavirus Vaccines for Coverage Against Rabies 
010 20230126413
 
D-GLUCOSE AND ITS ANALOGS AS TRACERS TO ASSESS THE GLUCOSE TRANSPORTER FUNCTION ON BLOOD-CEREBROSPINAL FLUID BARRIER AND THE FUNCTIONING OF THE BRAIN LYMPHATIC SYSTEM 
011 20230126784
 
A METHOD TO GENERATE CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS (CAR-T CELLS) FROM PATHOGEN-SPECIFIC CYTOTOXIC LYMPHOCYTES TO ENABLE THE SUBSEQUENT IN VIVO MODULATION OF THEIR FUNCTIONAL ACTIVITY 
012 20230126796
 
FUNCTIONAL AND THERAPEUTIC EFFECTS OF PAR4 CLEAVAGE BY CATHEPSIN G 
013 20230126916
 
Relatively constant sensor application pressure for electrical impedance myography 
014 20230126966
 
SYNTHETIC QUORUM-REGULATED LYSIS 
015 20230127123
 
ANTIBODIES AGAINST PD-L1 AND METHODS OF USE THEREOF 
016 20230127263
 
MODIFIED T CELLS AND METHODS OF PREPARING THE SAME 
017 20230127277
 
MICROBIOME-BASED THERAPEUTICS 
018 20230127304
 
NEW INHIBITORS FOR THE KEAP1-NRF2 PROTEIN-PROTEIN INTERACTION 
019 20230127401
 
MACHINE LEARNING SYSTEMS USING ELECTRONIC HEALTH RECORD DATA AND PATIENT-REPORTED OUTCOMES 
020 20230127462
 
Modified Tetracycline for Treatment of Alcohol Use Disorder, Pain and Other Disorders Involving Potential Inflammatory Processes 
021 20230127487
 
ASSESSING AND TREATING ACUTE DECOMPENSATED HEART FAILURE 
022 20230127548
 
METHODS FOR IDENTIFYING A CELL UPTAKE MECHANISM 
023 20230127630
 
IGF2BP2 INHIBITORS AND USES THEREOF 
024 20230127636
 
COMPOUNDS FOR TREATING ILK-MEDIATED DISEASES 
025 20230127823
 
Non-Invasive Gene Mutation Detection in Lung Cancer Patients 
026 20230127861
 
METHODS AND COMPOSITIONS FOR THE TREATMENT OF PULMONARY FIBROSIS USING VOLASERTIB 
027 20230127944
 
BROAD-SPECTRUM CARBAPENEMS 
028 20230127948
 
FIELD DEPLOYABLE CRISPR-CAS DIAGNOSTICS AND METHODS OF USE THEREOF 
029 20230128029
 
NEUROKININ ANTAGONISTS AND USES THEREOF 
030 20230128072
 
UV-LED Induction of Measurable Biological Endpoints 
031 20230128120
 
OMEGA MURICHOLIC ACID AS A PREGNANE X RECEPTOR LIGAND FOR TREATING HEPATO-INTESTINAL DISEASES 
032 20230128322
 
SYK KINASE INHIBITORS AS TREATMENT FOR MALARIA 
033 20230128340
 
SELECTIVE IMMUNODEPLETION OF ENDOGENOUS STEM CELL NICHE FOR ENGRAFTMENT 
034 20230128344
 
SITE-SPECIFIC ANTIBODY-DRUG CONJUGATES BY ADP-RIBOSYL CYCLASES 
035 20230128716
 
DEVICES, COMPOSITIONS AND METHODS FOR IMAGING WITH RAMAN SCATTERING 
036 20230128722
 
BEAD INCUBATION AND WASHING ON A DROPLET ACTUATOR 
037 20230128742
 
Systems and Methods for Communicating by Modulating Data on Zeros 
038 20230128967
 
SYSTEM, METHOD, AND COMPUTER PROGRAM PRODUCT FOR ADDITIVE MANUFACTURING OF BIOMIMETIC COMPONENTS FROM A BUILDING MATERIAL ON A MOVING BUILD PLATFORM 
039 20230129271
 
COMPOSITIONS AND METHODS FOR TREATING CANCER 
040 20230129326
 
METHODS TO PREVENT SARS-COV-2 INFECTION AND TREAT COVID-19 
041 20230129381
 
COMPOSITIONS AND METHODS FOR TREATMENT OF ANTICANCER-DRUG RESISTANT CANCERS 
042 20230129475
 
3D MICROELECTRODE ARRAYS (3D MEAS) WITH MULTIPLE SENSING CAPABILITIES FOR THE INVESTIGATION OF ELECTROGENIC CELLS 
043 20230129517
 
SYSTEM AND METHOD FOR TISSUE VIABILITY SCREENING 
044 20230129745
 
COMPOUNDS, COMPOSITIONS, AND METHODS TO TREAT METABOLIC DISEASE 
045 20230129789
 
METHODS FOR REGULATING FREE FATTY ACID FLUX USING FAT SPECIFIC PROTEIN 27 (FSP27) COMPOSITIONS 
046 20230130102
 
Na/K-ATPase LIGANDS AND USE THEREOF FOR TREATMENT OF CANCER 
047 20230130218
 
IMMUNOTHERAPEUTIC MODULATION OF AMYLOIDOGENIC DISEASE USING NON-FIBRILLOGENIC, NON-AMYLOIDOGENIC POLYMERIZED PROTEINS AND PEPTIDES 
048 20230130243
 
Method of Treating Urothelial Carcinoma and Other Genitourinary Malignancies Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N\'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 
049 20230130325
 
SERUM METABOLITES AS BIOMARKERS FOR CARNITINE TREATMENT OF SEPSIS 
050 20230130372
 
NOVEL DDR1 ANTIBODIES AND USES THEREOF 
051 20230130579
 
REGULATION OF POST-ISCHEMIC INFLAMMATORY RESPONSE: A NOVEL FUNCTION OF TYROSINE PHOSPHATASE STEP 
052 20230130602
 
INHIBITORS OF C. DIFFICILE SPORE GERMINATION 
053 20230130686
 
DEVICES AND SYSTEMS FOR DELIVERY OF MATERIALS TO CELLS 
054 20230130766
 
MONO AND COMBINATION THERAPIES WITH ULK1/2 INHIBITORS 
055 20230130791
 
A Combined Inhibition of EGFR and NRF2 in The Treatment of Malignant Glioma 
056 20230131140
 
HUMAN ORIGIN PROBIOTIC LACTOBACILIUS RHAMNOSUS HL-200 TO REDUCE LEAKY GUT BY METABOLIZING ETHANOLAMINE 
057 20230131219
 
USE OF AGONISTS TO AUGMENT CAR T FUNCTION IN SOLID TUMORS 
058 20230131243
 
METHODS OF ATTENUATING AN IMMUNE RESPONSE BY INHIBITION OF BFL1 
059 20230131376
 
ADJUVANT-ANTIBIOTIC COMBINATION AGAINST GRAM-NEGATIVE BACTERIA 
060 20230131501
 
THERAPEUTIC USES OF INHIBITORS OF THE RNA-BINDING PROTEIN HuR 
061 20230131668
 
HEAT SHOCK PROTEIN MODULATORS AND ANTI-HUNTINGTON DISEASE THERAPEUTIC AGENTS 
062 20230131867
 
TRITERPENE SAPONINS, METHODS OF SYNTHESIS AND USES THEREOF 
063 20230131972
 
RNA-Guided Transcriptional Regulation 
064 20230132012
 
VERTICAL-VIA ROTARY VALVES, MICROBIOREACTORS AND APPLICATIONS OF SAME 
065 20230132035
 
Toll-Like Receptor 8 (TLR8)-Specific Antagonists and Methods of Making and Uses Thereof 
066 20230132184
 
METHODS AND SYSTEMS FOR PHYSICAL EXPANSION AND IMAGING OF BIOLOGICAL SAMPLES 
067 20230132279
 
SHORT CHAIN CERAMIDE-BASED LIPIDS AND USES THEREOF 
068 20230132281
 
RNA SEQUENCING TO DIAGNOSE SEPSIS 
069 20230132355
 
DELIVERY OF CARD PROTEIN AS THERAPY FOR OCCULAR INFLAMMATION 
070 20230132381
 
SYNTHESIS OF FUNCTIONALIZABLE OR FUNCTIONALIZED POLY(3,4-ETHYLENEDIOXYTHIPHENE)-BASED POLYMERS AND MONOMERS THEREFOR 
071 20230132397
 
USE OF TOLL-LIKE RECEPTOR 2 (TLR-2) AGONIST FOR MODULATING HUMAN IMMUNE RESPONSE 

Up to Start Of Table

Take Me To The Details

Department of Defense (DOD) Agencies

Patent Title
001 20230125317
 
Avalanche Photodiodes with Adaptive Quenching of Photocurrent 
002 20230125788
 
TDP-43 MODULATING AGENTS AND USES THEREOF 
003 20230126905
 
LEAD LOCKING SYSTEM AND METHOD FOR IMPLANTABLE STIMULATORS 
004 20230127008
 
STAT3-TARGETED BASE EDITOR THERAPEUTICS FOR THE TREATMENT OF MELANOMA AND OTHER CANCERS 
005 20230127031
 
ROBUST FRAMEWORK FOR INTELLIGENT NEURAL INTERFACE SYSTEMS 
006 20230128143
 
METHOD FOR TREATING CANCER 
007 20230128159
 
SYSTEM FOR LUBRICATING COMPONENTS OF A GAS TURBINE ENGINE INCLUDING A LUBRICANT BYPASS CONDUIT 
008 20230128344
 
SITE-SPECIFIC ANTIBODY-DRUG CONJUGATES BY ADP-RIBOSYL CYCLASES 
009 20230131140
 
HUMAN ORIGIN PROBIOTIC LACTOBACILIUS RHAMNOSUS HL-200 TO REDUCE LEAKY GUT BY METABOLIZING ETHANOLAMINE 
010 20230131501
 
THERAPEUTIC USES OF INHIBITORS OF THE RNA-BINDING PROTEIN HuR 

Department of the ARMY (DOA)

Patent Title
001 20230125162
 
SIMULTANEOUS BEAMFORMING AND NULLFORMING FOR SECURE WIRELESS COMMUNICATIONS 
002 20230125788
 
TDP-43 MODULATING AGENTS AND USES THEREOF 
003 20230126296
 
SYSTEMS AND METHODS FOR GUIDED INTERVENTION 
004 20230126905
 
LEAD LOCKING SYSTEM AND METHOD FOR IMPLANTABLE STIMULATORS 
005 20230127861
 
METHODS AND COMPOSITIONS FOR THE TREATMENT OF PULMONARY FIBROSIS USING VOLASERTIB 
006 20230128071
 
MULTI-PIECE BUSHING 
007 20230128143
 
METHOD FOR TREATING CANCER 
008 20230128159
 
SYSTEM FOR LUBRICATING COMPONENTS OF A GAS TURBINE ENGINE INCLUDING A LUBRICANT BYPASS CONDUIT 
009 20230128344
 
SITE-SPECIFIC ANTIBODY-DRUG CONJUGATES BY ADP-RIBOSYL CYCLASES 
010 20230129487
 
SMALL MOLECULE BCL-2 FUNCTIONAL CONVERTERS AS CANCER THERAPEUTICS 
011 20230129562
 
SYSTEMS AND METHODS FOR OPTIMAL STATE TRANSFER AND ENTANGLEMENT GENERATION IN POWER-LAW INTERACTING SYSTEMS 
012 20230130671
 
Metal-Organic Chalcogenolates 
013 20230130711
 
SYSTEM AND METHOD FOR THERMIONIC ENERGY CONVERSION 
014 20230131140
 
HUMAN ORIGIN PROBIOTIC LACTOBACILIUS RHAMNOSUS HL-200 TO REDUCE LEAKY GUT BY METABOLIZING ETHANOLAMINE 
015 20230131501
 
THERAPEUTIC USES OF INHIBITORS OF THE RNA-BINDING PROTEIN HuR 
016 20230131958
 
Cosmetic and Dermatological Compositions 
017 20230131980
 
NERVE STIMULATION FOR TREATMENT OF DISEASES AND DISORDERS 

Department of the Navy (DON) | United States Marine Corps (USMC)

Patent Title
001 20230125317
 
Avalanche Photodiodes with Adaptive Quenching of Photocurrent 
002 20230127827
 
Broadband Diffractive Optical Element 
003 20230129777
 
Laser Deposition with a Reactive Gas 
004 20230129962
 
TONGUE JOINT INCLUDING MATING CHANNEL FOR COOLING 
005 20230131584
 
MULTI-TONE CONTINUOUS WAVE DETECTION AND RANGING 
006 20230131957
 
Unmanned Aerial Vehicle Self-Centering and Capture System and Related Methods 

Department of the Air Force (DAF)| United States Space Force (USSF)

Patent Title
001 20230126296
 
SYSTEMS AND METHODS FOR GUIDED INTERVENTION 
002 20230126388
 
INLINE PNEUMATIC VALVE WITH INTERNAL BUSHING 
003 20230127014
 
Method for Manufacturing Transparent Ceramic Materials 
004 20230130863
 
METHOD FOR SIGNAL REPRESENTATION AND RECONSTRUCTION 
005 20230131058
 
MAGNETIZATION-FREE FARADAY ROTATORS 
006 20230131116
 
Method of Evanescently Coupling Whispering Gallery Mode Optical Resonators Using Liquids 
007 20230132026
 
X-Ray Scintillators, Metal Halide Hybrids, Devices, and Methods 
008 20230132224
 
Quantum-Confined Stark Effect Electro-Optic Modulator In Perovskite Quantum Wells Integrated On Silicon 

Up to Start Of Table

Take Me To The Details
Patent Title
001 20230125131
 
ULTRAFAST LIGHT FIELD TOMOGRAPHY 
002 20230125793
 
METHOD OF MAKING HEXAGONAL BORON NITRIDE COATINGS AND COMPOSITIONS AND METHODS OF USING SAME 
003 20230126460
 
SYSTEM AND METHOD FOR PREDICTING MACHINE FAILURE 
004 20230126514
 
GENETICALLY ENGINEERED MICROORGANISMS THAT OVEREXPRESS MICROCIN-MGE AND METHODS OF PURIFICATION AND USE 
005 20230126566
 
TRACKING CONTINUOUSLY SCANNING LASER DOPPLER VIBROMETER SYSTEMS AND METHODS 
006 20230126916
 
Relatively constant sensor application pressure for electrical impedance myography 
007 20230127106
 
PINCHED TUBES FOR RECONFIGURABLE ROBOTS 
008 20230127524
 
FILAMENTOUS NANOSTRUCTURES AND THEIR USE FOR TREATMENT OF PULMONARY DISEASE 
009 20230127548
 
METHODS FOR IDENTIFYING A CELL UPTAKE MECHANISM 
010 20230127698
 
AUTOMATED STEREOLOGY FOR DETERMINING TISSUE CHARACTERISTICS 
011 20230127791
 
LASER MACHINING AND RELATED CONTROL FOR ADDITIVE MANUFACTURING 
012 20230127880
 
PLANT FEATURE DETECTION USING CAPTURED IMAGES 
013 20230128742
 
Systems and Methods for Communicating by Modulating Data on Zeros 
014 20230129378
 
SYSTEMS AND METHODS FOR DETECTION OF ANALYTES 
015 20230129434
 
ELECTROCHEMICAL THREE-DIMENSIONAL PRINTING AND SOLDERING 
016 20230129475
 
3D MICROELECTRODE ARRAYS (3D MEAS) WITH MULTIPLE SENSING CAPABILITIES FOR THE INVESTIGATION OF ELECTROGENIC CELLS 
017 20230129562
 
SYSTEMS AND METHODS FOR OPTIMAL STATE TRANSFER AND ENTANGLEMENT GENERATION IN POWER-LAW INTERACTING SYSTEMS 
018 20230130680
 
ROBOT SKIN APPARATUS, METHOD OF FABRICATING A ROBOT SKIN APPARATUS, AND A SYSTEM INCLUDING A ROBOT SKIN APPARATUS 
019 20230131300
 
Catalyst Compositions Including Metal Chalcogenides, Processes for Forming the Catalyst Compositions, and Uses Thereof 
020 20230131816
 
WEARABLE MICROPHONE JAMMER 
021 20230132011
 
AREA SELECTIVE NANOSCALE-THIN LAYER DEPOSITION VIA PRECISE FUNCTIONAL GROUP LITHOGRAPHY 
022 20230132026
 
X-Ray Scintillators, Metal Halide Hybrids, Devices, and Methods 
023 20230132034
 
Mesoporous MXene Powders Synthesized By Acid Or Base Induced Crumpling And Their Use As NA-Ion Battery Anodes 

Up to Start Of Table

Up to Start Of Table

Emerging Technology

Emerging Climate Change Technologies

Patents containing 'Y" CPC symbols indicate emerging technologies important to US scientific leadership.

Patent documents that contain a Y02 or Y04 CPC symbol are already classified elsewhere. USPTO add the Y symbols to the classification data is to monitor new technological development covering clean technology and inventions impacting climate change, important American science and technology interests.

Y02 — Green House Gas Mitigation — Y02 covers selected technologies, which control, reduce or prevent anthropogenic emissions of greenhouse gases (GHG), in the framework of the Kyoto Protocol and the Paris Agreement, and technologies that allow adapting to the adverse effects of climate change. Y02A covers technologies for adaptation to climate change, — technologies that allow adapting to the adverse effects of climate change in human, industrial (including agriculture and livestock), and economic activities. Y02P covers climate change mitigation technologies in any kind of industrial processing or production activity, including the agroalimentary industry (relating to agriculture and food), agriculture, fishing, ranching, and the like.

Y04 — Enabling Technologies — Y04 is focused on the information and communications inventions that facilitate climate change technology. Y04S covers systems integrating technologies related to power network operation, communication or information technologies for improving electrical power generation, transmission, distribution, management, or usage. Examples of the art covered here are technologies related to smart grids, home appliances, and systems supporting the interoperability of electric or hybrid vehicles.

About The Icons On the List Below

  • The icon takes you to the full text version of the patent application at USPTO;
  • The icon takes you to the PDF version of the patent application at USPTO; and
  • The icon takes you to the details about the patent on the FedInvent Details page.
  • When you use the icon the patent application you are interested appears at the top of the list on the details page.
Class
Y02A Technologies for Adaptation to Climate Change
20230125917  METHOD OF TREATING MICROBIAL INFECTIONS      

Count of patent applications funded by The Department of Health and Human Services (HHS).

Department | Agency This Week This Year
Department of Health and Human Services (HHS)711149
National Institutes of Health (NIH)691115
National Cancer Institute (NCI)16266
National Institute of General Medical Sciences (NIGMS)10179
National Institute of Allergy and Infectious Diseases (NIAID)10156
National Heart, Lung, and Blood Institute (NHLBI)9137
National Institute of Neurological Disorders and Stroke (NINDS)7101
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)674
National Institute of Biomedical Imaging and Bioengineering (NIBIB)579
National Human Genome Research Institute (NHGRI)434
National Institute of Child Health and Human Development (NICHD)336
National Institute of Mental Health (NIMH)242
NIH Office of the Director (NIHOD)221
National Institute of Environmental Health Sciences (NIEHS)213
National Institute on Aging (NIA)243
National Center for Advancing Translational Sciences (NCATS)226
National Institute on Drug Abuse (NIDA)121
National Institute on Alcohol Abuse and Alcoholism (NIAAA)15
National Eye Institute (NEI)127
National Center for Complementary and Integrative Health (NCCIH)13
National Center for Biotechnology Information (NCBI)11
Assistant Secretary for Preparedness and Response (ASPR)17
Biomedical Advanced Research and Development Authority (BARDA)16

Up to Start Of Table

Higher Education Research and Development (HERD)

FedInvent follows the HERD the Higher Education Research and Development institutions — the colleges and universities; research institutions, and medical schools that benefit from federal funding and rely on it to make important discoveries that drive American innovation. Taxpayer funded patents coming from mostly American and sometime foreign universities are an important indicia of the vitality of the American innovation ecosphere.

MEMBERS OF THE HERD

The National Science Foundation (NSF) Higher Education Research and Development (HERD) Survey is the primary source of information on R&D expenditures at 916 US colleges and universities that expended at least $150,000 in separately accounted for R&D in the fiscal year. We use the NSF list to keep track of which colleges and universities are receiving taxpayer-funded patents and filing patent applications.

WATCH This SPACE

We're working on our data analytics and will be reporting taxpayer-funded patents and patent applications shortly. In the meantime, FedInvent will post interesting information about the HERD Innovation Ecosphere here.

Top Ten Universities By R&D Expenditures
  1. Johns Hopkins University
  2. University of Michigan
  3. University of Washington
  4. University of California, San Diego
  5. University of California, San Francisco
  6. Columbia University in the City of New York
  7. Stanford University
  8. University Pittsburgh
  9. University Pennsylvania
  10. Duke University

Patent Applications by Scientific Domain.

This section contains the number of patents organiized by high level scientific and technical domain. The data is arranged by the first Cooperative Patent Classification System (CPC) patent symbol assigned to the patent. This indicates the scope and nature of the patented invention for a patent or a patent application.

Global patent offices use patent classification as their lingua franca — the common language — for exchanging information about inventions and what scientific and technical art a patent contains. The classifications assigned to a patent are used by patent examiners to find prior art and to determine if a particular patent's claims are novel. Patent classifications are also used for global enforcement of patent rights, treaties, and agreements.

Class Class Definition First
(Original)
Inventive
(CrossRef)
CPC A61 Medical or Veterinary Science; Hygiene 45 285
CPC C07 Organic Chemistry 22 65
CPC C12 Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or Genetic Engineering 14 55
CPC G06 Computing; Calculating; Counting 7 49
CPC G01 Measuring; Testing 8 34
CPC B01 Physical or Chemical Processes or Apparatus in General 4 35
CPC H04 Electric Communication Technique 5 21
CPC C25 Electrolytic or Electrophoretic Processes; Apparatus Therefor 2 19
CPC H01 Basic Electric Elements 6 10
CPC C23 Coating Metallic Material; Coating Material With Metallic Material; Chemical Surface Treatment; Diffusion Treatment of Metallic Material; Coating by Vacuum Evaporation, by Sputtering, by Ion Implantation or by Chemical Vapour Deposition, in General; Inhibiting Corrosion of Metallic Material or Incrustation in General 4 12
CPC B33 Additive Manufacturing Technology 0 12
CPC C04 Cements; Concrete; Artificial Stone; Ceramics; Refractories 1 10
CPC G21 Nuclear Physics; Nuclear Engineering 3 7
CPC F04 Positive - Displacement Machines for Liquids; Pumps for Liquids or Elastic Fluids 2 8
CPC H02 Generation; Conversion or Distribution of Electric Power 2 8
CPC B64 Aircraft; Aviation; Cosmonautics 2 7
CPC B29 Working of Plastics; Working of Substances in a Plastic State in General 1 6
CPC B25 Hand Tools; Portable Power-driven Tools; Manipulators 2 4
CPC C09 Dyes; Paints; Polishes; Natural Resins; Adhesives; Compositions Not Otherwise Provided For; Applications of Materials Not Otherwise Provided for 2 4
CPC G02 Optics 4 1
CPC B22 Casting; Powder Metallurgy 1 4
CPC G16 Information and Communication Technology [ICT] Specially Adapted for Specific Application Fields 1 4
CPC H05 Electric Techniques Not Otherwise Provided for 1 3
CPC F02 Combustion Engines; Hot-gas or Combustion-product Engine Plants 2 1
CPC F16 Engineering Elements and Units; General Measures for Producing and Maintaining Effective Functioning of Machines or Installations; Thermal Insulation in General 2 1
CPC B23 Machine Tools; Metal-working Not Otherwise Provided for 1 2
CPC C02 Treatment of Water, Waste Water, Sewage, or Sludge 1 2
CPC G05 Controlling; Regulating 1 2
CPC A47 Furniture; Domestic Articles or Appliances; Coffee Mills; Spice Mills; Suction Cleaners in General 1 1
CPC F24 Heating; Ranges; Ventilating 1 1
CPC G08 Signalling 1 1
CPC A01 Agriculture; Forestry; Animal Husbandry; Hunting; Trapping; Fishing 1 0
CPC C01 Inorganic Chemistry 1 0
CPC H03 Basic Electronic Circuitry 1 0
CPC Y02 Technologies or Applications for Mitigation or Adaptation Against Climate Change 0 1

Up to Start Of Table

Count of Inventors by Country and U.S. State

Patent Applications by country and state based on location information of first named inventors and all listed inventors.

Country First Named Inventors All Inventors
United States of America 151 566
Singapore 1 4
China PRC 0 11
Denmark 0 3
Italy 0 3
Germany 0 1
United Kingdom 0 1
Romania 0 1
Sweden 0 1
Taiwan 0 1
U.S. State First Named Inventors All Inventors
California 22 89
Massachusetts 17 62
Florida 11 34
Ohio 9 29
Maryland 9 20
New York 8 37
Texas 8 30
Connecticut 7 27
Missouri 6 17
Pennsylvania 5 24
Utah 5 19
Washington 4 23
Illinois 4 19
Tennessee 3 23
Colorado 3 12
North Carolina 3 9
Minnesota 3 7
Arkansas 2 12
Virginia 2 6
Indiana 2 4
New Jersey 2 3
Michigan 1 11
Kentucky 1 7
West Virginia 1 6
District of Columbia 1 5
Kansas 1 4
New Hampshire 1 3
South Carolina 1 3
Arizona 1 2
Delaware 1 2
Georgia 1 2
Mississippi 1 2
New Mexico 1 2
Nevada 1 2
Oregon 1 2
Rhode Island 1 2
Louisiana 1 1
Idaho 0 2
Vermont 0 2

Up to Start Of Table

Count of Assignees and Applicants by Country and U.S. State

Patent Applications by country and state based on location information of Assignees and Applicants.

Country Assignees Applicants
United States of America 47193
Germany 11
China Hong Kong 10
Denmark 02
China PRC 01
Japan 01
Singapore 01
U.S. State Assignees Applicants
Massachusetts 1321
California 729
New York 314
Maryland 310
Missouri 39
District of Columbia 213
Utah 29
North Carolina 28
Ohio 27
Washington 24
Virginia 21
Florida 114
Pennsylvania 18
Texas 16
Illinois 13
Kentucky 11
Oregon 11
Michigan 05
Colorado 04
Indiana 04
Tennessee 03
Arizona 02
Arkansas 02
Connecticut 02
Minnesota 02
Nevada 02
Delaware 01
Georgia 01
Kansas 01
Louisiana 01
New Hampshire 01
New Mexico 01
Rhode Island 01
West Virginia 01

Up to Start Of Table

Technology Center Explainer

How Tech Centers and Art Units Are Organized And Why It Matters

Patents travel from Technology Center to Art Unit to Group Art Unit to Patent Examiner.

The USPTO's patent corps is organized into Technology Centers (TCs), groups of patent examiners with specific scientific and technical domain expertise. Technology Centers are further divided into Art Units (AUs) organized by major types of inventive art within a scientific or technical domain. Art Units are organized into Group Art Units, even more specialized and granular teams of examiners.

Group Art Units (GAUs) are where patent examiners prosecute patent applications. Patent applications are docketed to examiners based on of specific subject matter classifications of a particular GAU.

Understanding Technology Centers, Art Units and Group Art Units helps you understand what type of inventions are being prosecuted within each scientific and technical domain, how long it takes from the date a patent application is filed to the time a final decision on the patentability of the invention is made.

Patents examined here cover:

Art Unit Technical & Scientific Domains
1610 Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
1620 Organic Chemistry
1630 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
1640 Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
1650 Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzyme
1660 Plants

About Plant Patents

Plant Patents are granted by the Government to an inventor who has invented or discovered and asexually reproduced a distinct and new variety of plant, other than a tuber propagated plant or a plant found in an uncultivated state. If you've ever eaten a pluot, you've enjoyed the fruit of a plant patent.

Plant patent numbers begin with a "PP" followed by a five digit number. The first Plant Patent was issued in 1931. Plant patents are valid for 20 years from the filing date.

Patents examined here cover:

Art Unit Technical & Scientific Domains
1710 Coating, Etching, Cleaning, Single Crystal Growth
1720 Fuel Cells, Batteries, Solar Cells, Liquid Crystal Composition
1730 Metallurgy, Metal Working, Inorganic Chemistry, Catalysts, Electrophotography, Photolithography
1740 Tires, Adhesive Bonding, Glass/Paper making, Plastics Shaping & Molding
1760 Organic Chemistry, Polymers, Compositions
1770 Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
1780 Miscellaneous Articles, Stock Material, Adhesive Composition, Fabrics
1790 Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry

Patents examined here cover:

Art Unit Technical & Scientific Domains
2110 Coating, Etching, Cleaning, Single Crystal Growth
2120 Miscellaneous Articles, Stock Material, Adhesive Composition, Fabrics
2130 Fuel Cells, Batteries, Solar Cells, Liquid Crystal Composition
2140/2170 Metallurgy, Metal Working, Inorganic Chemistry, Catalysts, Electrophotography, Photolithography
2150/2160 Tires, Adhesive Bonding, Glass/Paper making, Plastics Shaping & Molding
2180 Organic Chemistry, Polymers, Compositions
2190 Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus

Patents examined here cover:

Art Unit Technical & Scientific Domains
2410/2460/2470 Multiplex, VoIP
2420 Cable and Television
2430/2490 Cryptography and Security
2440/2450 Computer Networks
2480 Recording and Compression

Patents examined here cover:

Art Unit Technical & Scientific Domains
2610 Computer Graphic Processing, 3D Animation, Display Color Attribute, Object Processing, Hardware and Memory
2620 Selective Visual Display Systems
2630 Digital and Optical Communications
2640 Telecommunications: Analog Radio Telephone; Satellite and Power Control; Transceivers, Measuring and Testing; Bluetooth; Receivers and Transmitters; Equipment Details
2650 Videophones and Telephonic Communications; Audio Signals; Digital Audio Data Processing; Linguistics, Speech Processing and Audio Compression
2660 Digital Cameras; Image Analysis; Applications; pattern Recognition; Color and Compression; Enhancement and Transformation
2670 Facsimile; Printer; Color; halftone; Scanner; Computer Graphic Processing; 3-D Animation; Display Color; Attributes; Object Processing; Hardware and Memory
2680 Telemetry and Code Generation; Vehicles and System Alarms; Selective Communication; Dynamic Storage Systems; Mechanical parts of Disk Drives; Signal Processing and Control Processing in Disk Drives
2690 Selective Visual Display Systems

More broadly TC 2800 Art Units cover Semiconductors/Memory, Circuits/Measuring and Testing, Optics/Photocopying, Printing/Measuring and Testing.

Patents examined here cover:

Art Unit Technical & Scientific Domains
2810/2820/2890 Semiconductors/Memory
2830/2840 Electrical Circuits and Systems
2850/2860 Printing/Measuring and Testing
2870/2880 Optics

About Design Patents

The design FOR an article. Not to the design OF an article.

Patents examined here cover Design patents cover the appearance of an article. The design for an article consists of the visual characteristics embodied in or applied to an article. Since a design is manifested in appearance, the subject matter of a design patent application may relate to the configuration or shape of an article, to the surface ornamentation applied to an article, to the combination of configuration and surface ornamentation.

Design is inseparable from the article to which it is applied and cannot exist alone merely as a scheme of surface ornamentation. It must be a definite, preconceived thing, capable of reproduction and not merely the chance result of a method.

Design patent numbers begin with a "D" followed by a six-digit number. The first Design Patent was issued in 1843. The term of a design patent is 15 years measured from the date of grant if the design application was filed on or after May 13, 2015 (or 14 years if filed before May 13, 2015).

Patents examined here cover:

Art Unit Technical & Scientific Domains
3610 Surface Transportation
3620 Business Methods — Incentive Programs, Coupons; Operations Research; Electronic Shopping; Health Care; Point of Sale, Inventory, Accounting; Cost/Price, Reservations, Shipping and Transportation; Business Processing
3630 Static Structures, Supports and Furniture
3640 Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
3650 Material and Article Handling
3660 Computerized Vehicle Controls and Navigation, Radio Wave, Optical and Acoustic Wave Communication, Robotics, and Nuclear Systems
3670 Wells, Earth Boring/Moving/Working, Excavating, Mining, Harvesters, Bridges, Roads, Petroleum, Closures, Connections, and Hardware
3680 Business Methods — Incentive Programs, Coupons; Electronic Shopping; Business Cryptography, Voting; Health Care; Point of Sale, Inventory, Accounting; Business Processing, Electronic Negotiation
3690 Business Methods — Finance/Banking/ Insurance

Patents examined here cover:

Art Unit Technical & Scientific Domains
3710 Amusement and Education Devices
3720 Manufacturing Devices and Processes, Machine Tools and Hand Tools
3730 Sheet Container Making, Package Making, Receptacles, Shoes, Apparel, and Tool Driving or Impacting
3740 Thermal and Combustion Technology, Motive and Fluid Power Systems
3750 Fluid Handling and Dispensing
3760 Refrigeration, Vaporization, Ventilation, and Combustion
3770 Medical & Surgical Instruments, Treatment Devices, Surgery and Surgical Supplies
3780 Body Treatment, Kinestherapy, and Exercising

FedInvent Patents

Each week FedInvent analyzes newly granted patents and published patent applications whose origins lead back to funding from the US federal government. We assemble a weekly patent catalog and analyze the inventions, the inventors, and the entities who received the patents. We map the patents back to the agency that funded the R&D that led to the new invention. FedInvent uses the funding opportunity descriptions, the grants, and the contracts that define the research areas of interest ,and the R&D policies and priorities of that drove and are driving the funding to organize each week's patents.

ABOUT OUR DATA

The weekly patent catalog includes patents with government interest statements indicating federal funding; and patents where the assignee, the owner of the invention, is the federal government. This includes work on federal grants, work on federal contracts, innovation by Federal Research and Development Centers (FFRDCs) funded by Federal Departments, and University Affiliated Research Centers funded by DoD.

Not every inventor is a government contractor. There are many inventions conceived and patented by scientists and engineers working for the federal government or serving in the military.

THE NUMBERS MAY NOT MATCH THE NUMBER OF PATENTS WE ANALYZE EACH WEEK

The numbers in the tables presented on this page will not add up to the number of patents granted each week because patents are counted by each agency that funded the creation of the invention. Patents and funding have a many-to-many relationship. One patent may have more than one funding grant or contract associated with it. A grant or contract may lead to more than one patent. More than one agency may have funded the inventors or the contract. More than one university or business may have worked together on an invention. When we report the numbers here, we associate a patent with all of the entities and funding that are reflected on the patent and report them to you. This approach presents a more complete picture of what's going on in the federal innovation ecosphere. Put another way, the numbers in the tables presented on this page may not always add up to the number of patents each week because patents are counted by each agency that funded the creation of the invention.

Subscribe to The FedInvent™ Newsletter

 The latest from FedInvent delivered right to your inbox.